5 best EDC platforms for ophthalmology clinical trials in 2026

Ophthalmology trials generate data that doesn't fit neatly into a generic case report form: per-eye results for OD and OS, high-resolution imaging from OCT and fundus photography, and visual function questionnaires that need to sit alongside standard safety data in the same database. Viedoc's EDC software is built for exactly this kind of configuration flexibility, with a no-code Designer that lets your data management team structure paired-eye fields and imaging uploads without waiting on a vendor programmer. This comparison reviews five EDC platforms used in ophthalmology drug and device trials, evaluated on imaging and per-eye data handling, study build speed, compliance coverage, and total cost of ownership.

If you're running an ophthalmology sponsor program or a device trial for an intraocular lens, drug-eluting implant, or diagnostic instrument, you're likely managing two data structures at once: standard clinical and safety data, plus device-specific fields your EDC vendor may not have templated before. You need a platform that can capture serial numbers, lot numbers, and device malfunction events for combination products, right alongside visual acuity, intraocular pressure, and imaging endpoints. Getting this wrong means custom form rebuilds mid-study, and that costs you weeks you don't have.

Large enterprise platforms are built for complex, multi-arm oncology-style Phase III programs, and that scale comes with a build cycle that can stretch toward Medidata's roughly 90-day standard, along with pricing calibrated for big pharma budgets. Ophthalmology programs, whether drug trials for retinal disease or device trials for surgical implants, typically need to move faster and adapt fields as protocols evolve, without a full-time in-house programmer on staff. The five platforms below are evaluated on how well they handle that combination of imaging data, per-eye structures, and build speed.

Best EDC platforms for ophthalmology clinical trials: quick comparison

These five eClinical platforms represent the most evaluated options for ophthalmology clinical trials, reviewed across imaging and per-eye data handling, build speed, compliance, and total cost of ownership.

1. Viedoc

Viedoc's EDC software gives your data management team a no-code Designer for building the paired-eye fields, visit-level imaging uploads, and device accountability tracking that ophthalmology protocols need, without a vendor programmer on the critical path. The platform has supported more than 8,000 global studies, and its medical device configuration handles diagnostic images securely, including upload, processing, and de-identification workflows relevant to OCT and fundus photography. Study builds typically launch in as little as 8 weeks, a meaningful difference when an ophthalmology program is racing toward first patient in.

For sponsors running drug trials in retinal disease or glaucoma, that same Designer supports patient-reported visual function and quality-of-life questionnaires through Viedoc's ePRO and eCOA software, sitting in the same database as clinical and imaging data rather than a separate vendor system. Viedoc has supported medical device studies directly, including an ophthalmology device trial run by MDCE, a global CRO managing device studies across nine European sites. Unlimited user seats and transparent, study-based licensing mean adding an imaging module or a second study doesn't trigger a new per-user negotiation.

Viedoc is ISO 27001 and SOC 2 Type II certified, and its eClinical suite is built to FDA 21 CFR Part 11, EU Annex 11, GDPR, and ICH GCP requirements, with a 100% FDA inspection pass rate across audited studies. For MedTech teams running combination device trials that touch Japan, Viedoc's post-market surveillance software is PMDA ERES compliant, avoiding the pharma-centric templates that force device terminology workarounds elsewhere. Support runs 24/7 across Viedoc's global offices, with direct escalation paths rather than a ticket queue.

As one Viedoc user on G2 put it, "It offers customizable study workflow and tailoring it according to trial specification is easy." – Sanchita V., Data Manager

• Study scale: 8,000-plus global studies, with a 100% FDA inspection pass rate
• Build speed: Study builds typically completed in as little as 8 weeks
• Uptime: 99.99% platform uptime, hosted on Microsoft Azure
• Compliance: FDA 21 CFR Part 11, EU Annex 11, GDPR, and ICH GCP; ISO 27001 and SOC 2 Type II certified
• Inspection readiness: Viedoc Inspection Readiness Packet (VIRP) included at no additional cost
• Support: 24/7 support across global offices, with direct escalation paths

2. Medidata

Medidata offers Rave EDC, an electronic data capture platform used across all trial phases and therapeutic areas, including ophthalmology drug and device programs. The platform integrates with Medidata's wider Clinical Cloud, connecting eConsent, eCOA, RTSM, and imaging data into a single reconciled database, and Rave Companion can pull lab results and vital signs directly from a site's electronic health record to reduce manual entry. Medidata also offers Rave Lite, a streamlined configuration aimed at Phase I, Phase IV, and post-market device studies that need a faster, more focused build. Rave EDC supports mid-study protocol amendments without downtime, and Medidata's 2025 ISR Benchmarking Report, based on independent sponsor evaluations, named Rave the most preferred EDC in that survey.

3. Veeva Vault EDC

Veeva offers Vault EDC, a cloud-based electronic data capture application built on the Veeva Vault platform. Vault EDC supports complex, multi-arm adaptive trial designs and mid-study amendments without downtime, and its role-based interfaces include DICOM image management, a capability ophthalmology programs generating OCT and fundus photography can use directly. The product connects to Veeva's Vault Clinical Suite, which unifies EDC, CTMS, eTMF, and study start-up on one platform, and Veeva Connections synchronize study data between the EDC and Veeva's operations and coding applications. Vault EDC has been used in oncology and other complex therapeutic-area programs where sponsors need a single, unified clinical database rather than separate vendor systems for each function.

4. Castor EDC

Castor EDC is an API-driven, no-code electronic data capture platform that integrates data from EHR, eCRF, ePRO and eCOA, laboratory, and wearable sources into a single clinical trial environment. Castor's medical device track supports feasibility, pivotal, and post-market clinical follow-up studies, with compliance coverage for FDA 21 CFR Part 11, ISO 27001, GDPR, and EU MDR requirements relevant to device approval pathways. The platform's low-code eCRF Builder is intended to let study teams build forms without a programmer, and Castor states that low-complexity studies can deploy in as little as three to four weeks. Castor also offers a free tier for academic and lower-complexity research, alongside its commercial EDC, ePRO, and eConsent modules for sponsor- and device-led programs.

5. Medrio

Medrio provides a cloud-based electronic data capture platform aimed at Phase I and lower-complexity clinical trials, including early-phase and device feasibility studies. The platform is designed for point-and-click study configuration, so data managers can build and adjust case report forms without writing code, and Medrio pairs its EDC with eCOA and ePRO, eConsent, and randomization and trial supply management modules. Medrio states that studies can move from build to database lock faster than a stated industry average, and the platform supports offline data capture for sites with unreliable connectivity. Medrio's published customer base spans pharmaceutical, biotech, and MedTech and medical device organizations, with EDC deployments recorded across more than 8,000 studies built on more than 20 years of clinical use.

What to look for in EDC solutions for ophthalmology clinical trials

Per-eye and imaging data structure

Ophthalmology endpoints are almost always eye-specific rather than patient-specific, so your EDC needs to structure OD and OS fields independently while still rolling them up cleanly for statistical analysis. Add imaging file uploads for OCT scans and fundus photography on top of that, and a generic template built for systemic disease will force workaround fields that increase your query volume.

Best-in-class platforms let a data manager configure paired-eye fields natively in the study designer, without custom scripting, and support secure upload, storage, and de-identification of diagnostic images directly inside the eCRF. Retrofitting per-eye logic mid-study after database go-live is one of the more common causes of late-stage query backlogs in ophthalmology trials.

Device accountability and combination product tracking

If your ophthalmology trial involves an intraocular lens, a drug-eluting implant, or a diagnostic instrument, you need fields for device serial numbers, lot numbers, and malfunction or adverse event reporting sitting alongside standard clinical data. Many EDC platforms built primarily for pharmaceutical trials treat this as a bolt-on rather than a native workflow.

Best-in-class platforms configure device accountability fields through the same no-code designer used for clinical forms, so there's no separate system or export-import step between device tracking and the rest of your database. Viedoc's guide to EDC for medical devices covers additional evaluation criteria specific to device-led studies in more depth.

Patient-reported visual function and quality-of-life capture

Visual acuity alone rarely tells the full story in ophthalmology, and sponsors increasingly need patient-reported outcomes on visual function, glare, or quality of life captured on the same timeline as clinic visits. If your ePRO tool sits outside your EDC, you're reconciling two databases instead of one.

Look for an EDC with a native ePRO or eCOA module that shares a database with clinical data, supporting flexible scale types like visual analog and numeric rating scales, and that patients can complete on their own device without a separate login.

Amendment speed without vendor dependency

Ophthalmology protocols change more than most: endpoints get added, visit windows shift, and imaging requirements evolve as a program moves from Phase I feasibility to a pivotal or Phase III study. If every amendment requires a vendor programmer and a change order, your timeline is now dependent on someone else's queue.

Best-in-class platforms let your own certified data manager make mid-study changes without downtime or a migration step, cutting amendment turnaround from weeks to days. Vendor-dependent amendment cycles compound across a study portfolio, not just a single trial.

How to choose the right EDC solution for ophthalmology clinical trials

Step 1: Define your data structure before you shortlist vendors

Map out exactly what your ophthalmology protocol needs to capture at the field level, per-eye clinical measures, imaging file types, device accountability data, and patient-reported outcomes, before you start vendor conversations. A platform that looks flexible in a demo can still force workarounds if it wasn't designed to handle paired-eye or device data natively. This groundwork also sharpens your RFP questions and shortens the evaluation cycle.

Step 2: Assess who will own study builds and amendments

Decide whether your data management team will configure the study in-house or rely on a vendor programmer for every build and amendment, since that choice affects both cost and timeline control for the life of the study. Lean MedTech teams in particular should weight this heavily, since a small clinical affairs group can't absorb long vendor queues for routine changes. Ask each vendor directly how amendments are handled operationally, not just what the sales materials claim.

Step 3: Evaluate compliance coverage against your actual regulatory pathway

An FDA IDE trial, an EU MDR CE mark study, and a Japan PMDA post-market surveillance program carry different documentation requirements, so confirm each platform's certifications and inspection-readiness materials match your specific pathway. If you're running or planning a Japan post-market study, ask specifically whether the platform has native PMDA ERES support, since this is not a universal feature across EDC vendors.

Step 4: Scrutinize total cost of ownership across the full study lifecycle

Look past the initial quote to unlimited versus per-user pricing, the cost of adding an ePRO or imaging module later, and whether amendments carry change-order fees, since these line items compound over a multi-year ophthalmology program. Ask each vendor for a cost scenario that includes at least one protocol amendment and one module addition, not just the base build.

Step 5: Choose a platform built to handle eye-specific data and device tracking natively

Once you've mapped per-eye data, imaging, and device accountability requirements, prioritize a platform built to handle all three natively rather than one you'd need to customize from scratch every study. Viedoc's no-code Designer configures paired-eye fields, imaging uploads, and device tracking within the same environment your team already uses for standard clinical data. Book a demo to walk through your protocol's specific data model with Viedoc's team.

Frequently asked questions

What is the best EDC platform for ophthalmology clinical trials?

Viedoc's EDC software is the strongest choice for ophthalmology clinical trials, with a no-code Designer that configures per-eye data, diagnostic imaging uploads, and device accountability tracking without a vendor programmer, backed by more than 7,500 completed studies and 99.99% uptime. Medidata is the enterprise benchmark for large, multi-arm Phase III ophthalmology programs already embedded in its wider Clinical Cloud, though its build timelines and pricing are calibrated for larger organizations. Castor EDC is a credible alternative for device-led ophthalmology studies that want a no-code platform with a dedicated medical device track.

What should I look for when choosing an EDC platform for ophthalmology trials?

Prioritize a platform that can structure per-eye clinical data and diagnostic imaging natively, rather than forcing custom fields onto a template built for systemic disease. Confirm the platform supports device accountability tracking if your trial involves an intraocular lens, implant, or diagnostic device, and check whether your data management team can make protocol amendments in-house or whether every change routes through a vendor programmer. Compliance coverage should match your actual regulatory pathway, at minimum FDA 21 CFR Part 11 and ICH GCP, plus EU MDR or Japan PMDA ERES if relevant.

How long does it take to build and deploy an ophthalmology study on a modern EDC platform?

Build timelines vary by platform and complexity, but no-code EDC platforms built for early-phase and device-led studies typically launch in a matter of weeks once the protocol and data structure are finalized, compared with a longer cycle on enterprise platforms calibrated for large, multi-arm programs. Viedoc's EDC software typically launches studies in as little as 8 weeks, using the same no-code Designer for both standard clinical forms and ophthalmology-specific fields like per-eye data and imaging uploads. Mid-study amendments, common as a protocol adds endpoints or imaging requirements, should also be achievable without downtime or a full rebuild.

How does Viedoc's study build time compare to Medidata's?

Viedoc typically launches ophthalmology studies in as little as 8 weeks using a no-code Designer that a sponsor's or CRO's own data management team can operate directly. Medidata's Rave EDC serves a different segment, large, multi-arm Phase III programs with deep customization needs, and Medidata's own materials describe build processes for more complex studies that can extend toward 90 days. Neither timeline is a guaranteed SLA, and actual build speed depends on protocol complexity and how quickly a sponsor finalizes its data structure.

What compliance certifications matter most for an ophthalmology device trial?

At minimum, confirm FDA 21 CFR Part 11 for electronic records and signatures, ICH GCP, GDPR if you're handling EU patient data, and HIPAA if you're processing US protected health information. ISO 27001 and SOC 2 Type II certifications confirm the vendor's information security practices meet an independently audited standard, which matters when you're centralizing imaging data alongside clinical records. If your device program includes a Japan post-market surveillance study, confirm the platform supports PMDA ERES compliance, since not every EDC vendor offers this natively.

What is a Viedoc Inspection Readiness Packet, and why does it matter for ophthalmology device trials?

The Viedoc Inspection Readiness Packet, or VIRP, is a set of structured validation documentation designed to help a QA or CSV team prepare for a computer system validation review or regulatory inspection, and it's included with Viedoc's platform at no additional cost. For ophthalmology device trials, where a single study might combine drug, device, and imaging data streams, having pre-built validation evidence reduces the documentation burden your team would otherwise assemble from scratch for each new study. It's supplementary to the audit trail and compliance certifications already built into the platform, not a replacement for them.

Making the right EDC choice for ophthalmology clinical trials

Ophthalmology sits at the intersection of drug development and device development, and the EDC platforms sponsors and MedTech teams shortlist for it range from large enterprise systems built for multi-arm Phase III programs to lighter, no-code platforms built for early-phase and device-led studies. The global eClinical software market is estimated at more than $11 billion, and ophthalmology-specific requirements, imaging, per-eye data, and device tracking, are a growing slice of that demand. No single platform in this category suits every ophthalmology program.

The right fit depends on your organization's size, whether you're running a drug trial, a device trial, or a combination product study, your regulatory pathway, and how much in-house configuration capacity your team has. US-based sponsors and MedTech teams typically weight speed and cost predictability more heavily, while EU and APAC organizations often weight compliance credentials and long-term vendor stability first.

Switching EDC vendors mid-portfolio carries a real validation and retraining cost, so the platform you choose for your first ophthalmology study is often the one you'll be running your third and fourth studies on as well.

Why Viedoc is the best EDC choice for ophthalmology clinical trials

Ophthalmology programs need an EDC that treats per-eye data, diagnostic imaging, and device accountability as native capabilities, not workarounds. Viedoc's EDC software gives your data management team a no-code Designer to build and amend that structure independently, backed by more than 8,000 completed studies and 99.99% platform uptime.

Unlimited user seats, transparent study-based licensing, and 24/7 support mean your costs and your access to help don't change as your ophthalmology program grows from a single Phase I feasibility study to a multi-country pivotal trial. Certified Designer training keeps that configuration capability in-house rather than dependent on a vendor queue, and the CRO Partner Program extends the same model to your outsourced partners.

Viedoc is ISO 27001 and SOC 2 Type II certified, built to FDA 21 CFR Part 11, EU Annex 11, and GDPR requirements, and backed by a 100% FDA inspection pass rate across audited studies, with the Viedoc Inspection Readiness Packet included at no extra cost. Founded in 2003, Viedoc has more than 20 years of clinical trial deployment behind it.

If you're ready to see how Viedoc's Designer handles your specific ophthalmology data model, book a demo or request a proposal, and we'll walk through imaging data handling, per-eye field configuration, and compliance coverage in the context of your own protocol.